Frontier Wealth Management LLC Eli Lilly & CO Transaction History

Frontier Wealth Management LLC

$8.02 Billion
Q2 2022

A detailed history of Frontier Wealth Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Frontier Wealth Management LLC holds 6,092 shares of LLY stock, worth $5.35 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

6,092

Previous 6,092 -0.0%

Holding current value

$5.35 Million

Previous $1.88 Million -0.0%

% of portfolio

0.02%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $36,513 - $42,872	131 Added 2.15%	6,223 $2.02 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $151,375 - $188,120	645 Added 11.84%	6,092 $1.88 Million
Q4 2021 Feb 04, 2022	BUY	$224.85 - $279.04 $164,140 - $203,699	730 Added 15.48%	5,447 $1.51 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $124,096 - $152,717	-560 Reduced 10.61%	4,717 $1.09 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $10,833 - $14,012	60 Added 1.15%	5,277 $1.21 Million
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $45,680 - $59,136	278 Added 5.63%	5,217 $975,000
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $17,612 - $23,305	-135 Reduced 2.66%	4,939 $834,000
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $1,462 - $1,691	-10 Reduced 0.2%	5,074 $751,000
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $101,905 - $122,642	747 Added 17.22%	5,084 $835,000
Q1 2020 May 08, 2020	BUY	$119.05 - $147.35 $99,644 - $123,331	837 Added 23.91%	4,337 $602,000
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $39,453 - $48,866	-369 Reduced 9.54%	3,500 $460,000
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $32,464 - $35,312	-304 Reduced 7.28%	3,869 $433,000
Q2 2019 Aug 16, 2019	BUY	$110.79 - $129.32 $19,609 - $22,889	177 Added 4.43%	4,173 $462,000
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $9,127 - $10,743	82 Added 2.1%	3,996 $519,000
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $7,518 - $8,423	-71 Reduced 1.78%	3,914 $453,000
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $5,323 - $6,653	62 Added 1.58%	3,985 $428,000
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $5,450 - $6,255	-72 Reduced 1.8%	3,923 $335,000
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $561,769 - $663,132	-7,570 Reduced 65.46%	3,995 $309,000
Q4 2017 Feb 14, 2018	SELL	$81.94 - $87.89 $466,976 - $500,885	-5,699 Reduced 33.01%	11,565 $977,000
Q3 2017 Nov 13, 2017	SELL	$77.07 - $85.54 $32,292 - $35,841	-419 Reduced 2.37%	17,264 $1.48 Million
Q2 2017 Aug 14, 2017	BUY	N/A	17,683	17,683 $1.46 Million

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $834B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Wealth Management LLC with notifications on news.

Account

Frontier Wealth Management LLC Eli Lilly & CO Transaction History